{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Fibrillization or conformational change of α-synuclein is central in the pathogenesis of α-synucleinopathies, such as Parkinson disease. A30P mutation affects the conformation and fibrillization of both WT and A30P.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links α-synuclein fibrillization and conformational changes to Parkinson disease pathogenesis, with A30P mutation directly impacting these processes."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Electron microscopy, ultracentrifugation, immunochemical analysis, and protease-resistant core assays were used to study fibrillization and conformational changes.",
          "judgment": "Yes",
          "reasoning": "The assays (electron microscopy, ultracentrifugation, immunochemical analysis) directly model the disease mechanism by analyzing protein aggregation and conformational changes relevant to α-synucleinopathies.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "A30P fibrils were tested with WT seeds and vice versa, showing cross-seeding effects. Controls included WT fibrils and protease-resistant core analysis.",
          "judgment": "Yes",
          "reasoning": "Variant controls (A30P vs. WT seeds) were used, and standard methods (protease-resistant cores, epitope-specific antibodies) were employed to validate conformational changes.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "A30P accelerates fibrillization of WT α-synuclein and exhibits distinct conformational properties. No explicit OddsPath calculation was reported.",
          "judgment": "No OddsPath Calculation",
          "reasoning": "The paper does not report statistical analyses or OddsPath calculations, but the functional effect (accelerated fibrillization) is demonstrated with variant controls.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "strength": "PS3_supporting",
      "type": "Pathogenic"
    }
  ]
}